Pei Kang
Managing Director @ Chengwei Capital
Shanghai, China
Pei Kang is a seed investor at Chengwei Capital in Shanghai focused on Medical and Genetics. Mr. Pei Kang serves as the Managing Director of Chengwei Capital. Mr. Kang joined Chengwei Capital in 2003. He serves as Board Observer of Polyera Corporation. He served as Senior Vice President of WK Technology Fund. He led WK's investment activities in China and made several investments in software and manufacturing sectors. Heserved as a Senior Executive at IBM for over 18 years. He served as General Manager of financial service sector in China at IBM. Mr. Kang has been a Director at Huaya Microelectronics, Inc. since December 6, 2004. He served as a Non Executive Director of AAC Technologies Holdings Inc. from February 15, 2007 to May 02, 2010. He holds BS from Chinese Culture University of Taiwan.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Pei Kang invests in
Stages Pei Kang invests in
Countries Pei Kang invests in
Investment Focus
Industry
- Medical 1 (25%)
- Genetics 1 (25%)
- Software 1 (25%)
- Biopharma 1 (25%)
- Automotive 1 (25%)
Stage
- Seed 1 (25%)
- Angel 1 (25%)
- Series A 1 (25%)
- Series C 1 (25%)
Country
- China 2 (50%)
- United States 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Jushu Biotech
|
Jushu Biotech is a medical engineering company that focuses on the research and development of synthetic biosensing technology. | $13.9M / Seed / Nov 17, 2023 | |
|
Jushu Biotech
|
Jushu Biotech is a medical engineering company that focuses on the research and development of synthetic biosensing technology. | $1.3M / Angel / Jan 13, 2023 | |
Raythink Technology
|
Raythink is committed to the research and development of innovative applications of vehicle-mounted AR display products, providing customers with a highly reusable AR Generator ecological software platform, which enables the vehicle HMI system to continuously embed independent software algorithms/applications, and convert them into AR displaygraphics and visual effects. | $15M / Series A / Jun 07, 2022 | |
Polyera
|
The Polyera Corporation is "a leading supplier in semiconductor, dielectric, and interfacial materials for the printed and flexible electronics industry. Polyera is focused on developing breakthrough materials for its portfolio of ActivInkâ„¢ products and on working closely with customers to provide deep technical support and customizedsolutions in order to enable the commercialization of novel printed and flexible electronic products." | Series C / Apr 05, 2012 |
Co-Investors
3E Bioventures
2 deals together
Binhu State Investment
1 deal together
China Unicom
1 deal together
Empower Investment
1 deal together
Solvay
1 deal together
Tsing Capital
1 deal together
About Chengwei Capital
Chengwei Ventures is a venture capital firm.
Chengwei Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Pei Kang
Managing Director
|
|||
|
Dong Chengxian
Managing Director
|
|||
Eric X Li
Founder, Managing Director
|
|||
|
Lou Qun
Managing Director
|
|||
Ping Ping
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Pei Kang invest in?
Pei Kang invests primarily in Medical, Genetics and Software startups, most often at Seed and Angel stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Pei Kang last invest?
The most recent investment recorded for Pei Kang closed in Nov 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
